Metraipolis › archive › dc_a8d920aef34c

Atorvastatin as a pleiotropic anticancer agent: mechanisms, evidence, and therapeutic repurposing potential — Europe PMC PMID:42112329

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42112329
DOI
10.3389/fimmu.2026.1808729
License (as archived)
solo-consultazione
Archived
2026-11-03T07:35:34.452Z
SHA-256 of the archived text
cdba58c5f3e050db8e261f26cf41a032419c28dc9ff2fde0f28fe1b127a85c16
Stable URL of this page
https://metraipolis.com/documento/dc_a8d920aef34c

How to cite

Atorvastatin as a pleiotropic anticancer agent: mechanisms, evidence, and therapeutic repurposing potential — Europe PMC PMID:42112329 — Europe PMC (en), https://europepmc.org/article/MED/42112329 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a8d920aef34c (Metraipolis archive dc_a8d920aef34c, sha256 cdba58c5f3e050db8e261f26cf41a032419c28dc9ff2fde0f28fe1b127a85c16)
BibTeX
@misc{dca8d920aef34c,
  title = {Atorvastatin as a pleiotropic anticancer agent: mechanisms, evidence, and therapeutic repurposing potential — Europe PMC PMID:42112329},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42112329},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a8d920aef34c; sha256 cdba58c5f3e050db8e261f26cf41a032419c28dc9ff2fde0f28fe1b127a85c16},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42112329. Agents can read the archived copy with the MCP tool read_document.